378 search results
- Current search:
- Has podcast
- Reset
Primary tabs
- Cochrane Evidence (active tab)
- Resources
- Handbooks & Manuals
- Training & Workshops
- News
- All Cochrane sites
-
UpdatedCochrane EvidencePublished 21 Jun 2017
Anti-vascular endothelial growth factor (anti-VEGF) drugs for diabetic macular oedema
What is the aim of this review? The aim of this Cochrane Review was to find out which is the best type of anti-VEGF drug for diabetic macular oedema (DMO). Cochrane researchers collected and analysed all relevant studies to answer this question and found 24 studies. Key messages Anti-VEGF drugs given by injection into the eye improve vision in people ... -
Cochrane EvidencePublished 4 May 2017
The use of vibrating devices to help people with cystic fibrosis clear their airways of mucus
Review question We reviewed the evidence about the effect of vibrating devices (e.g. Flutter, acapella, cornet, Quake®, intrapulmonary percussive ventilation, high frequency chest wall oscillators (e.g. Vest®), VibraLung® and MetaNeb®) to help people with cystic fibrosis clear their airways of mucus. This is an update of a previously published review. Background People ... -
Cochrane EvidencePublished 20 Apr 2017
Hydroxyurea (also known as hydroxycarbamide) for people with sickle cell disease
Review question What is the effect of hydroxyurea on clinical outcomes (changes in pain crises, life-threatening illnesses, survival, haemoglobin levels, quality of life and side effects) in people with sickle cell disease (SCD) of any genotype? Background SCD is an inherited genetic disorder that creates problems with haemoglobin (the substance ... -
Cochrane EvidencePublished 18 Apr 2017
Strategies to help people with asthma take their steroid inhaler as prescribed
Background to the question Inhalers containing steroids improve asthma-related symptoms and reduce asthma attacks when taken regularly. But many people with asthma do not take them as prescribed. This leads to more symptoms and flare-ups, which have been linked to a third of asthma deaths in the UK. Missing doses is sometimes called 'non-adherence'. ... -
Cochrane EvidencePublished 31 Mar 2017
Medical interventions to prevent graft rejection after liver transplantation
Background Liver transplantation is the main treatment option for people with severe advanced liver disease. When organs or tissues are transplanted from one person (organ donor) to another (organ recipient), the body of the organ recipient identifies the donor organ (or graft) as a foreign body and mounts a response against it in a way similar to ... -
Cochrane EvidencePublished 14 Mar 2017
Clinical effects of cardiovascular risk scores in people without cardiovascular disease
Review question What is the evidence about the potential clinical benefits and harms of providing cardiovascular disease (CVD) risk scores in people without a history of heart disease or stroke? Background Cardiovascular disease (CVD) is a group of conditions that includes heart disease and stroke. CVD prevention guidelines emphasise the use ... -
Cochrane EvidencePublished 28 Feb 2017
Support for breastfeeding mothers
What is the issue? The World Health Organization recommends that infants should be breastfed exclusively until six months of age with breastfeeding continuing as an important part of the infant’s diet until he or she is at least two years old. We know that breastfeeding is good for the short-term and long-term health of both infants and their mothers. ... -
Cochrane EvidencePublished 21 Feb 2017
Buprenorphine for managing opioid withdrawal
Review question We reviewed the evidence about the effect of buprenorphine for managing withdrawal in people who are dependent on opioid drugs (for example, heroin or pharmaceutical opiates). Background Managed withdrawal, or detoxification, is a required first step for long-term treatment of opioid dependence. The combination of uncomfortable symptoms ... -
Cochrane EvidencePublished 9 Feb 2017
Fixed daily dose of a low molecular weight heparin compared with an adjusted dose of unfractionated heparin for treating blood clots in the deep veins
Background Venous thromboembolism (VTE) is a condition in which a blood clot forms in the deep veins of the leg or pelvis (DVT) or the clot travels in the blood and blocks a blood vessel in the lungs (pulmonary embolism (PE)). The chances of getting a VTE can be increased if people have risk factors such as previous clots, prolonged periods of immobility ... -
Cochrane EvidencePublished 9 Feb 2017
Improving how physicians working in hospital settings prescribe antibiotics
Review aim The aim of this Cochrane review was to learn of ways to improve how physicians working in hospital settings prescribe antibiotics. We collected and analysed all relevant studies to answer this question and found 221 studies. Key messages The use of an antibiotic policy leads to improved prescribing practices and decreases in the duration ...
